These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 21979097)
1. Elucidation of crucial structures for a catechol-based inhibitor of plasma hyaluronan-binding protein (factor VII activating protease) autoactivation. Yamamoto E; Kitano Y; Hasumi K Biosci Biotechnol Biochem; 2011; 75(10):2070-2. PubMed ID: 21979097 [TBL] [Abstract][Full Text] [Related]
2. Inhibitors of autoactivation of plasma hyaluronan-binding protein (factor VII activating protease). Yamamoto E; Nishimura N; Okada K; Sekido C; Yamamichi S; Hasumi K Biol Pharm Bull; 2011; 34(4):462-70. PubMed ID: 21467630 [TBL] [Abstract][Full Text] [Related]
3. Extracellular histone induces plasma hyaluronan-binding protein (factor VII activating protease) activation in vivo. Yamamichi S; Fujiwara Y; Kikuchi T; Nishitani M; Matsushita Y; Hasumi K Biochem Biophys Res Commun; 2011 Jun; 409(3):483-8. PubMed ID: 21600885 [TBL] [Abstract][Full Text] [Related]
4. The cyclopentapeptide plactin enhances cellular binding and autoactivation of the serine protease plasma hyaluronan-binding protein. Yamamoto E; Yamamichi S; Choi-Miura NH; Hasumi K Thromb Res; 2010 Nov; 126(5):406-13. PubMed ID: 20864147 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of plasma hyaluronan-binding protein autoactivation by laccaic acid. Sekido C; Nishimura N; Takai M; Hasumi K Biosci Biotechnol Biochem; 2010; 74(11):2320-2. PubMed ID: 21071862 [TBL] [Abstract][Full Text] [Related]
6. Polyamine-promoted autoactivation of plasma hyaluronan-binding protein. Yamamichi S; Nishitani M; Nishimura N; Matsushita Y; Hasumi K J Thromb Haemost; 2010 Mar; 8(3):559-66. PubMed ID: 19817990 [TBL] [Abstract][Full Text] [Related]
7. Purpurin as a specific inhibitor of spermidine-induced autoactivation of the protease plasma hyaluronan-binding protein. Nishimura N; Takai M; Yamamoto E; Hasumi K Biol Pharm Bull; 2010; 33(8):1430-3. PubMed ID: 20686243 [TBL] [Abstract][Full Text] [Related]
8. Regulation mechanism of the serine protease activity of plasma hyaluronan binding protein. Choi-Miura NH; Saito K; Takahashi K; Yoda M; Tomita M Biol Pharm Bull; 2001 Mar; 24(3):221-5. PubMed ID: 11256474 [TBL] [Abstract][Full Text] [Related]
9. Proteolytic activation and inactivation of the serine protease activity of plasma hyaluronan binding protein. Choi-Miura NH; Takahashi K; Yoda M; Saito K; Mazda T; Tomita M Biol Pharm Bull; 2001 May; 24(5):448-52. PubMed ID: 11379758 [TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells. Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202 [TBL] [Abstract][Full Text] [Related]
11. Activation of proPHBSP, the zymogen of a plasma hyaluronan binding serine protease, by an intermolecular autocatalytic mechanism. Etscheid M; Hunfeld A; König H; Seitz R; Dodt J Biol Chem; 2000 Dec; 381(12):1223-31. PubMed ID: 11209757 [TBL] [Abstract][Full Text] [Related]
12. Protease pro region required for folding is a potent inhibitor of the mature enzyme. Baker D; Silen JL; Agard DA Proteins; 1992 Apr; 12(4):339-44. PubMed ID: 1579568 [TBL] [Abstract][Full Text] [Related]
13. Novel human plasma proteins, IHRP (acute phase protein) and PHBP (serine protease), which bind to glycosaminoglycans. Choi-Miura NH Curr Med Chem Cardiovasc Hematol Agents; 2004 Jul; 2(3):239-48. PubMed ID: 15320789 [TBL] [Abstract][Full Text] [Related]
14. Solid-phase synthesis of a library based on biphenyl-containing trypsin-like serine protease inhibitors. Shi S; Zhu S; Gerritz SW; Rachwal B; Ruan Z; Hutchins R; Kakarla R; Sofia MJ; Sutton J; Cheney D Bioorg Med Chem Lett; 2009 Nov; 19(22):6477-80. PubMed ID: 19804972 [TBL] [Abstract][Full Text] [Related]
15. Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts. de la Cruz L; Nguyen TH; Ozawa K; Shin J; Graham B; Huber T; Otting G J Am Chem Soc; 2011 Nov; 133(47):19205-15. PubMed ID: 22007671 [TBL] [Abstract][Full Text] [Related]
16. Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP). Nakazawa F; Kannemeier C; Shibamiya A; Song Y; Tzima E; Schubert U; Koyama T; Niepmann M; Trusheim H; Engelmann B; Preissner KT Biochem J; 2005 Feb; 385(Pt 3):831-8. PubMed ID: 15654766 [TBL] [Abstract][Full Text] [Related]
17. Proteases universally recognize beta strands in their active sites. Tyndall JD; Nall T; Fairlie DP Chem Rev; 2005 Mar; 105(3):973-99. PubMed ID: 15755082 [No Abstract] [Full Text] [Related]
18. A positively charged cluster in the epidermal growth factor-like domain of Factor VII-activating protease (FSAP) is essential for polyanion binding. Altincicek B; Shibamiya A; Trusheim H; Tzima E; Niepmann M; Linder D; Preissner KT; Kanse SM Biochem J; 2006 Mar; 394(Pt 3):687-92. PubMed ID: 16332249 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of human cytomegalovirus protease N(o) with monocyclic beta-lactams. Déziel R; Malenfant E Bioorg Med Chem Lett; 1998 Jun; 8(11):1437-42. PubMed ID: 9871780 [TBL] [Abstract][Full Text] [Related]
20. Prolyl endopeptidase inhibitors from caryophylli flos. Lee KH; Kwak JH; Lee KB; Song KS Arch Pharm Res; 1998 Apr; 21(2):207-11. PubMed ID: 9875432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]